| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +46.6% |
| Cost of Revenue | $866K | +174.0% |
| Gross Profit | $2.3M | +24.4% |
| R&D Expense | $189K | +592.0% |
| SG&A Expense | $2.1M | +59.1% |
| Pre-tax Income | -$272K | -581.2% |
| Income Tax | $0 | — |
| Net Income | -$272K | -581.2% |
| EPS (Basic) | $0.00 |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $850K | +64.4% |
| Accounts Receivable | $231K | -57.7% |
| Inventory | $42K | +89.5% |
| Current Assets | $1.2M | +4.2% |
| Total Assets | $1.3M | -0.0% |
| Current Liabilities | $1.5M | +23.5% |
| Total Liabilities | $1.5M | +16.0% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $415K | +316.6% |
| Capital Expenditures | $32K | +399.5% |
| Investing Cash Flow | -$82K | -61.7% |
| Free Cash Flow | $383K | +310.9% |
| — |
| EPS (Diluted) | $0.00 | — |
| Stockholders' Equity |
| -$202K |
| -4010.2% |